Publication | Closed Access

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Metastatic Breast CancerBreast OncologyElderly PatientsMedicineCancer ManagementLocally RecurrentBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation Oncology